Literature DB >> 20730633

Implementing pharmacy practice research programs for the management of heart failure.

Michael D Murray1.   

Abstract

It stands to reason that pharmacists would have a beneficial role in the treatment of patients with chronic illnesses wherein complicated pharmacotherapies are required to reduce the risk of acute exacerbation. For chronic heart failure, recent evidence bears this out. When pharmacists take time to provide self-care instructions for patients with heart failure or take part in collaborative healthcare teams, the need for costly urgent healthcare decreases with corresponding decreases in healthcare costs. Further research is needed to address the key supportive roles of pharmacists in the treatment of patients with heart failure.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20730633     DOI： 10.1007/s11096-010-9424-7

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN： 0928-1231


  10 in total

1.  Heart failure management programs reduce readmissions and prolong survival.

Authors:  Simon Stewart; Finlay A McAlister; John J V McMurray
Journal:  Arch Intern Med       Date:  2005-06-13

2.  A multicenter disease management program for hospitalized patients with heart failure.

Authors:  Ross T Tsuyuki; Miriam Fradette; Jeffrey A Johnson; Tammy J Bungard; Dean T Eurich; Thomas Ashton; Wendy Gordon; Roland Ikuta; Jan Kornder; Elizabeth Mackay; Dante Manyari; Ken O'Reilly; William Semchuk
Journal:  J Card Fail       Date:  2004-12       Impact factor: 5.712

3.  NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.

Authors:  E R Heerdink; H G Leufkens; R M Herings; J P Ottervanger; B H Stricker; A Bakker
Journal:  Arch Intern Med       Date:  1998-05-25

Review 4.  Underutilization of evidence-based therapies in heart failure: the pharmacist's role.

Authors:  Jo Ellen Rodgers; Wendy Gattis Stough
Journal:  Pharmacotherapy       Date:  2007-04       Impact factor: 4.705

5.  Home-based intervention in congestive heart failure: long-term implications on readmission and survival.

Authors:  Simon Stewart; John D Horowitz
Journal:  Circulation       Date:  2002-06-18       Impact factor: 29.690

6.  Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease.

Authors:  Michael D Murray; Mary E Ritchey; Jingwei Wu; Wanzhu Tu
Journal:  Arch Intern Med       Date:  2009-04-27

7.  Predicting mortality in patients with heart failure: a pragmatic approach.

Authors:  M L Bouvy; E R Heerdink; H G M Leufkens; A W Hoes
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

8.  Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills.

Authors:  M D Murray; W Tu; J Wu; D Morrow; F Smith; D C Brater
Journal:  Clin Pharmacol Ther       Date:  2009-03-04       Impact factor: 6.875

9.  Pharmacist intervention to improve medication adherence in heart failure: a randomized trial.

Authors:  Michael D Murray; James Young; Shawn Hoke; Wanzhu Tu; Michael Weiner; Daniel Morrow; Kevin T Stroupe; Jingwei Wu; Daniel Clark; Faye Smith; Irmina Gradus-Pizlo; Morris Weinberger; D Craig Brater
Journal:  Ann Intern Med       Date:  2007-05-15       Impact factor: 25.391

10.  Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study.

Authors:  Marcel L Bouvy; Eibert R Heerdink; John Urquhart; Diederick E Grobbee; Arno W Hoes; Hubert G M Leufkens; Arno W Hoe
Journal:  J Card Fail       Date:  2003-10       Impact factor: 5.712
  10 in total
  2 in total

1.  Pharmacy students' anxiety towards research during their undergraduate degree; How to reduce it?

Authors:  Mari Kannan Maharajan; Kingston Rajiah; Ai May Tam; Siew Ling Chaw; May Jing Ang; Mei Wan Yong
Journal:  PLoS One       Date:  2017-04-18       Impact factor: 3.240

Review 2.  A Review of the Role of the Pharmacist in Heart Failure Transition of Care.

Authors:  Sarah L Anderson; Joel C Marrs
Journal:  Adv Ther       Date:  2018-02-27       Impact factor: 3.845
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.